MetInfo enterprise content manager system | MetInfo CMS


Mesenchymal Stem Cells:

Mesenchymal stem cells (MSCs) are multipotent, and can differentiate into multiple cell types, including adipocytes, cartilage, bone, tendons, muscle, and skin. MSCs have been used in preclinical models for tissue engineering of bone, cartilage, muscle, marrow stroma, tendon, fat, and other connective tissues. MSCs have also been used to treat heart failure and acute heart infarction due to their ability to differentiate into cardiomyocytes and vascular endothelial cells and to secrete angiogenic and anti-apoptotic factors. MSCs also have strong immune suppressive function, which is being used to treat many autoimmune diseases.


MetInfo enterprise content manager system | MetInfo CMS


hESC now can be differentiated into MSC with high efficiency and purity without cell supply concerns. hESC have great advantages over traditional adult-tissue derived MSCs, such as bone marrow MSC (BM-MSC), placenta MSC (hPMSC). See our Stem Cell Report publication for detail.

See the chart below for comparison between hES-MSC and BM-MSC




BM-MSC(adult-tissue derived)

Origin of cell

Human Embryonic Stem cell

Bone marrow or Placenta


Unlimited, stable

Limited supply

Quality variance


Donor variance
Batch variance
Passage Variance
Manufacture variance

Immunosuppressive activity

Strong both in vitro/in vivo

poor, or not working


Resistant to environment change

Changes after expansion and infusion into different patient




Foreign pathogen


Possible, need test every donor




Inflammatory cytokine release


Medium to high

Manufacture Time/cost

Short, low

Long, variable



MetInfo enterprise content manager system | MetInfo CMS


There are many ways to derive MSC from hES cells. Our proprietary method of derive MSC from hES cells are the most efficient method, with shortest time, highest yield and purity. This method outperforms other current methods by at least 200 times in cell yield, 50~80% less the processing time, 75% less the manufacturing cost. We have confirmed that our T-MSC have strong therapeutic effects in multiple sclerosis animal model. In our recent study, we have also confirmed that our cells outperform all adult-tissue derived mesenchymal stem cells in treating multiple autoimmune diseases.


T-MSC Platform:

T-MSC is not only a product or technology, but also a platform can be widely used in many areas as show below:

MetInfo enterprise content manager system | MetInfo CMS